Extracorporeal Shockwave Lithotripsy (ESWL<sup>®</sup>): A Chronology

Chaussy, Ch.; Eisenberger, F.; Forssmann, Bernd

doi:10.1089/end.2007.9880

Cited by 61 publications

(34 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Stone radiodensity may be determined either by plain radiography or CT attenuation values. Utilizing plain X-rays the radiodensity of the stone is referred to that of the ipsilateral 12th rib [10] or to the spine [11] . The attenuation value of urinary stones measured in Hounsfield unit (HU) on CT scan seems to be more accurate as a predictor of stone composition, fragility and stone-free status after ESWL [9,12,13] .…”

Section: Stone Variablesmentioning

confidence: 99%

ESWL Prediction of Outcome and Failure Prevention

et al. 2007

View full text Add to dashboard Cite

Based on our own experiences and a review of the recent literature, this article evaluates recent developments in predicting outcomes and failures of shockwave lithotripsy when treating patients with urinary tract stones. After a detailed MEDLINE research, the authors identified several variables that influence and predict extracorporeal shockwave lithotripsy (ESWL) success. These variables may be categorized as stone variables, patient variables and operator variables. Only multivariate analysis on a large number of homogenous patients may offer an objective evaluation of the factors conditioning ESWL outcome.

show abstract

Section: Stone Variablesmentioning

confidence: 99%

ESWL Prediction of Outcome and Failure Prevention

et al. 2007

View full text Add to dashboard Cite

show abstract

“…1 It is currently considered to be an effective first-line modality of therapy for renal and ureteral calculi. SWL is very appealing because of its noninvasive nature, minimal anesthesia requirement, and high level of patient and physician acceptance.…”

Section: Introductionmentioning

confidence: 99%

“…6 KIM-1 is excreted in urine and thus has been used as a biomarker for acute kidney injury mostly in the renal transplant population. 7 Despite the observation that KIM-1 has outperformed other kidney injury markers of ischemia, it 1 has not yet been evaluated in patients undergoing SWL. The goal of this study was to test urinary KIM-1 and NAG concentration before and after SWL.…”

Section: Introductionmentioning

confidence: 99%

Urinary Expression of Novel Tissue Markers of Kidney Injury After Ureteroscopy, Shockwave Lithotripsy, and in Normal Healthy Controls

Fahmy

Şener

Sabbisetti

et al. 2013

Journal of Endourology

View full text Add to dashboard Cite

Background and Purpose: Shockwave lithotripsy (SWL) and ureteroscopy (URS) are minimally invasive treatment alternatives for kidney stones. Although less invasive, SWL subjects the renal parenchyma to a high level of energy and the potential to cause renal injury. The ability to detect renal injury post-SWL in a reliable and noninvasive way would be clinically beneficial. Kidney injury molecule 1 (KIM-1) and N-acetyl-b-Dglucosaminidase (NAG) are two proteins secreted by the kidney into the urine and have been found to be sensitive markers of acute kidney injury in transplant patients. The aim of this work was to measure urinary levels of KIM-1 and NAG in patients with kidney stone who were treated by SWL or URS and in nonstone volunteers. Patients and Methods: Patients with kidney stones who were treated by SWL (n = 50) or URS (n = 10) were recruited. Voided urine samples were collected before and 2 to 3 hours after URS and SWL. In addition, further urinary specimens were collected 2 days and 2 weeks post-SWL treatment. Voided urine samples from healthy volunteers were also collected. Results: Mean KIM-1 values were increased in patients with kidney stones when compared with volunteers. KIM-1 and NAG levels significantly increased post-SWL and returned to baseline within 2 weeks post-SWL. Poor kidney function was significantly associated with increased biomarker activity both in baseline and post-SWL measurements. There was no significant change in urinary KIM-1 and NAG concentrations before and after URS. Conclusions: Kim-1 and NAG levels significantly increased post-SWL treatment suggesting a potential role for these urinary markers in identifying patients at higher risk of tissue injury.

show abstract

“…The immediate side effects of SWL are parenchymal bleeding, hematoma around the capsule, and edematous changes around the kidney and adjacent organs. Renal ultrasonography immediately after SWL has shown that the incidence of hematoma is 0.6% [19] . However, this incidence elevates to as high as 25% when computerized tomography or MRI is used after SWL [20,21] .…”

Section: Discussionmentioning

confidence: 99%

Is Extracorporeal Shock Wave Lithotripsy Really Safe in Long-Term Follow-Up? A Nationwide Retrospective 6-Year Age-Matched Non-Randomized Study

Chien²,

Chou³

et al. 2016

Urol Int

View full text Add to dashboard Cite

Introduction: Shock wave lithotripsy (SWL) is widely used. However, several studies have reported increased blood pressure immediately after SWL. Until now, the association between SWL and new-onset hypertension has been a topic of discussion. This study is aimed at determining whether SWL leads to new-onset hypertension. Methods: Data were sourced from the Longitudinal Health Insurance Database 2000 of Taiwan, Republic of China, which was compiled from 1996 to 2010 using National Health Insurance data. Patients who had undergone SWL were compared with controls that were matched for age, sex, obesity, diabetes mellitus, and hyperlipidemia. Results: Patients who had undergone SWL had a higher incidence of new-onset hypertension compared to the control groups. Furthermore, new hypertension developed faster in the SWL group. Conclusions: The results of this study demonstrated that an association exists between nephrolithiasis patients who were treated with SWL and subsequent hypertension diagnosis. Patients who undergo SWL may need regular follow-up of blood pressure.

show abstract

Extracorporeal Shockwave Lithotripsy (ESWL^®): A Chronology

Cited by 61 publications

References 11 publications

ESWL Prediction of Outcome and Failure Prevention

ESWL Prediction of Outcome and Failure Prevention

Urinary Expression of Novel Tissue Markers of Kidney Injury After Ureteroscopy, Shockwave Lithotripsy, and in Normal Healthy Controls

Is Extracorporeal Shock Wave Lithotripsy Really Safe in Long-Term Follow-Up? A Nationwide Retrospective 6-Year Age-Matched Non-Randomized Study

Contact Info

Product

Resources

About

Extracorporeal Shockwave Lithotripsy (ESWL®): A Chronology

Cited by 61 publications

References 11 publications

ESWL Prediction of Outcome and Failure Prevention

ESWL Prediction of Outcome and Failure Prevention

Urinary Expression of Novel Tissue Markers of Kidney Injury After Ureteroscopy, Shockwave Lithotripsy, and in Normal Healthy Controls

Is Extracorporeal Shock Wave Lithotripsy Really Safe in Long-Term Follow-Up? A Nationwide Retrospective 6-Year Age-Matched Non-Randomized Study

Contact Info

Product

Resources

About

Extracorporeal Shockwave Lithotripsy (ESWL^®): A Chronology